Technology areas: Biotechnology & Pharmaceuticals • Chemistry & Materials
2 pending office actions • 2 art units • 2 examiners • 0 of 2 (0%) have an AI response strategy ready • 4 patents granted in the last 365 days
Quest Diagnostics Investments Incorporated has 2 pending office actions in the Chemistry & Materials technology area. These 2 pending office actions are distributed across 2 distinct art units, meaning each matter is being reviewed in a different technical classification. The company is also working with 2 distinct examiners, so each action has a unique reviewer. This 1:1 ratio of actions to examiners and art units means there is no overlap or concentration in the company's current prosecution.
FRITCHMAN, REBECCA M is the busiest examiner, with 1 pending office action. In this small portfolio, each of the 2 distinct examiners handles exactly one case. The distribution across 2 distinct art units suggests that the company's chemical innovations are being treated as distinct technical challenges. Practitioners must handle each of the 2 pending office actions as independent cases with no shared examiner or art unit context. The small scale of 2 pending office actions allows for a high-intensity focus on each individual matter in the Chemistry & Materials area.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §103 only | 1 (50%) |
| Double-patenting + other | 1 (50%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| FRITCHMAN, REBECCA M | 1 | 45.6% | +35.4% |
| SINGH, SATYENDRA K | 1 | 61.5% | +67.9% |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 2 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 19462819 | MASS SPECTROMETRY OF STEROIDAL COMPOUNDS IN MULTIPLEX SAMPLES | FRITCHMAN, REBECCA M | — |
| 18884490 | MASS SPECTROMETRY METHOD FOR MEASURING THIAMINE IN BODY FLUID | SINGH, SATYENDRA K | — |
| Art Unit | Apps |
|---|---|
| 1758 | 1 |
| 1657 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 19462819 | MASS SPECTROMETRY OF STEROIDAL COMPOUNDS IN MULTIPLEX SAMPLES | FRITCHMAN, REBECCA M | 1758 | §103 | Final Rejection | — | Pending | Jan 28, 2026 |
| 18884490 | MASS SPECTROMETRY METHOD FOR MEASURING THIAMINE IN BODY FLUID | SINGH, SATYENDRA K | 1657 | §103§112DP | Non-Final OA | — | Pending | Sep 13, 2024 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialQuest Diagnostics Investments Incorporated has 2 pending office actions as of October 2026, spread across 2 art units and 2 examiners.
Rebecca M Fritchman has the most, with 1 of Quest Diagnostics Investments Incorporated's pending office actions.
Mostly Chemistry & Materials (USPTO Tech Center 1700), based on where its pending office actions are examined.
